Everence Capital Management’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
Everence Capital Management's GH Position: Q3 2026 in Review
Everence Capital Management reduced its Guardant Health (GH) stake by 0.91% in Q3 2026, selling an estimated $6.05K and leaving 4,043 shares worth $721K. The position accounts for 0.04% of the portfolio, ranked #313.
Everence Capital Management first reported a position in GH in Q2 2025 and has held it in 6 quarters since. 676 funds tracked by Wall St. Rank hold GH as of Q3 2026.
- Everence Capital Management held 4,043 shares of Guardant Health worth $721K as of Q3 2026.
- Everence Capital Management sold 37 Guardant Health shares in Q3 2026, an estimated $6.05K.
- Guardant Health made up 0.04% of Everence Capital Management's portfolio in Q3 2026, its #313 holding.
- Everence Capital Management first reported a position in Guardant Health in Q2 2025 and has held it in 6 quarters since.
- 676 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.
Based on Everence Capital Management's 13F filing for Q3 2026, filed 3 Nov 2026.